Cyrus Biotechnology
Cyrus Biotechnology is an AI-driven discovery company specializing in naturally existing proteins engineered into superior therapeutics using AI and deep mutagenesis. Their platform integrates novel algorithms and advanced laboratory methods to rapidly develop biologics, focusing on severe autoimmune diseases and therapeutic immuno cytokines. Key products include IdeS for IgG-driven autoimmune diseases, an IL-22 fusion protein for autoimmune gastrointestinal and metabolic indications, and a COVID-19 prophylaxis candidate effective against all variants. The company has over 30 discovery programs with partners and collaborations with top biotech firms, positioning it as a leader in AI-powered protein design for autoimmune therapeutics.
Cyrus Biotechnology
Cyrus Biotechnology is an AI-driven discovery company specializing in naturally existing proteins engineered into superior therapeutics using AI and deep mutagenesis. Their platform integrates novel algorithms and advanced laboratory methods to rapidly develop biologics, focusing on severe autoimmune diseases and therapeutic immuno cytokines. Key products include IdeS for IgG-driven autoimmune diseases, an IL-22 fusion protein for autoimmune gastrointestinal and metabolic indications, and a COVID-19 prophylaxis candidate effective against all variants. The company has over 30 discovery programs with partners and collaborations with top biotech firms, positioning it as a leader in AI-powered protein design for autoimmune therapeutics.